Comparison between Global Longlife Hospital IPO and Nanavati Ventures IPO.
Global Longlife Hospital IPO is a SME Fixed Price IPO proposed to list at BSE SME while Nanavati Ventures IPO is a SME Fixed Price proposed to list at BSE SME.
| Global Longlife Hospital IPO | Nanavati Ventures IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | First Overseas Capital Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Rikhav Securities Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Global Longlife Hospital IPO is up to ₹46.54 Cr whereas the issue size of the Nanavati Ventures IPO is up to ₹2.07 Cr. The final issue price of Global Longlife Hospital IPO is ₹140.00 per share and of Nanavati Ventures IPO is ₹50.00 per share.
| Global Longlife Hospital IPO | Nanavati Ventures IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹140.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 1000 shares | 3000 shares |
| Fresh Issue Size | 33,24,000 shares | 4,14,000 shares |
| Fresh Issue Size (Amount) | up to ₹46.54 Cr | up to ₹2.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 33,24,000 shares | 4,14,000 shares |
| Issue Size Total (Amount) | up to ₹46.54 Cr | up to ₹2.07 Cr |
Global Longlife Hospital IPO opens on Apr 21, 2022, while Nanavati Ventures IPO opens on Apr 25, 2022. The closing date of Global Longlife Hospital IPO and Nanavati Ventures IPO is Apr 25, 2022, and Apr 27, 2022, respectively.
| Global Longlife Hospital IPO | Nanavati Ventures IPO | |
|---|---|---|
| Issue Open | Apr 21, 2022 | Apr 25, 2022 |
| Issue Close | Apr 25, 2022 | Apr 27, 2022 |
| Basis Of Allotment (Tentative) | May 02, 2022 | |
| Initiation of Refunds (Tentative) | May 04, 2022 | |
| Credit of Share (Tentative) | May 05, 2022 | |
| Listing date (Tentative) | May 04, 2022 | May 06, 2022 |
Global Longlife Hospital IPO P/E ratio is 38.04, as compared to Nanavati Ventures IPO P/E ratio of 61.73.
| Global Longlife Hospital IPO | Nanavati Ventures IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.43% | 71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 54.29% | 52.19% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 38.04 | 61.73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹147.00 Cr. | ₹8.23 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.48 | ₹99.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 11.54 | 1.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Global Longlife Hospital IPO Retail Individual Investors (RII) are offered 16,62,000 shares while in Nanavati Ventures IPO retail investors are offered 16,62,000 shares. Qualified Institutional Buyers (QIB) are offered in Global Longlife Hospital IPO and in Nanavati Ventures IPO.
| Global Longlife Hospital IPO | Nanavati Ventures IPO | |
|---|---|---|
| Market Maker Reservation | 1,76,000 shares | 24,000 shares |
| NII | 16,62,000 shares | 2,06,000 shares |
| RII | 16,62,000 shares | 2,06,000 shares |
| Total | 33,24,000 shares | 4,12,000 shares |
Global Longlife Hospital IPO subscribed 1.50x in total, whereas Nanavati Ventures IPO subscribed 32.52x.
| Global Longlife Hospital IPO | Nanavati Ventures IPO | |
|---|---|---|
| NII (times) | 1.60x | 13.86x |
| RII (times) | 1.40x | 51.17x |
| Total (times) | 1.50x | 32.52x |
